Arcuro Medical
Series A in 2025
Arcuro Medical Ltd. is focused on developing advanced solutions for meniscus repair in the knee. Established in 2013 and based in Misgav, Israel, the company has introduced its proprietary SuperBall repair system, which features a knotless all-suture anchor and a unique delivery mechanism designed for anatomic joint repair. This innovative system allows medical professionals to perform meniscus repairs safely and effectively within the joint space using specialized suture material, addressing the needs of patients with meniscus tears. Through its technology, Arcuro Medical aims to enhance the quality and reliability of meniscus repair procedures.
ViAqua Therapeutics
Venture Round in 2023
Founded in 2014, ViAqua Therapeutics is based in Israel. The company specializes in developing drugs and therapeutics for aquaculture, focusing on the first orally administered treatment to prevent viral diseases.
Phytolon Ltd is a company based in Misgav, Israel, specializing in the development of natural food colorants. Founded in 2000, Phytolon utilizes a novel fermentation technology that employs baker's yeast cells as biofactories to produce high-quality, plant-based food colors. This innovative approach offers a healthy alternative to synthetic food dyes, providing food manufacturers with safe, cost-effective, and stable all-natural color solutions. The company's mission is to leverage scientific advancements to promote human health and environmental sustainability in the food industry.
FruitSpec
Series A in 2021
FruitSpec develops hyperspectral imaging and deep learning based technology to estimate fruit yields and manage the fruit value chain. The company designs sensor pods that scan orchards and pairs them with a software platform to count fruits, determine size distribution, and estimate total yield. It offers yield estimation as a service, delivering reports that show the number of fruits and size distribution for a given orchard, with an additional heat-map visualization of fruit quantities. The solutions enable agribusinesses, including farmers, distributors, and insurers, to capture farm data and make planning decisions. Founded in 2016 and based in Tel Aviv, Israel, FruitSpec targets early-season insights to support demand-to-supply management across the fruit industry.
Fidmi Medical
Venture Round in 2021
Founded in Israel in 2014, Fidmi Medical specializes in developing innovative enteral feeding devices. Their products aim to improve nutrition delivery by offering easy insertion, replacement, and removal, enhancing the quality of life for patients who cannot consume food orally.
AgroScout
Series A in 2021
AgroScout Ltd. is an Israeli company established in 2017 that specializes in developing an artificial intelligence-based platform aimed at enhancing sustainable farming practices. The company's technology provides precision agriculture solutions by utilizing advanced analytics and high-resolution aerial imagery to assess crop health and monitor for pests and diseases. AgroScout's platform supports farmers by offering insights on crop emergence, stand counts, canopy coverage, and biomass throughout the growing season. This continuous monitoring allows for early detection of infestations, enabling more effective curative treatments and reducing pesticide use. By delivering actionable insights into crop management and regional outbreak predictions, AgroScout aims to improve crop yields and profitability while fostering a more sustainable food production supply chain.
ViAqua Therapeutics
Venture Round in 2021
Founded in 2014, ViAqua Therapeutics is based in Israel. The company specializes in developing drugs and therapeutics for aquaculture, focusing on the first orally administered treatment to prevent viral diseases.
Phytolon
Funding Round in 2020
Phytolon Ltd is a company based in Misgav, Israel, specializing in the development of natural food colorants. Founded in 2000, Phytolon utilizes a novel fermentation technology that employs baker's yeast cells as biofactories to produce high-quality, plant-based food colors. This innovative approach offers a healthy alternative to synthetic food dyes, providing food manufacturers with safe, cost-effective, and stable all-natural color solutions. The company's mission is to leverage scientific advancements to promote human health and environmental sustainability in the food industry.
Vessi Medical
Venture Round in 2020
Vessi Medical is an Israeli medical device startup focused on innovating treatment for Non-Muscle-Invasive Bladder Cancer (NMIBC) through a novel surface cryotherapy approach. This technique employs extreme cold to freeze and eliminate abnormal tissue, providing a minimally invasive alternative to the standard TransUrethral Resection of Bladder Tumor (TURBT), which is often inadequate and requires invasive surgery under general anesthesia. Vessi's technology, comprising a standalone console and a disposable catheter, allows for targeted cell destruction while safeguarding healthy bladder tissue. This office-based procedure not only reduces the need for costly hospital stays and repeat surgeries but also addresses the high recurrence rate of NMIBC, which affects millions globally. With promising proof of concept already demonstrated in animal studies, Vessi aims to capture the $1.2 billion NMIBC market, while also exploring future applications for treating overactive bladder and urinary tract infections. The company is supported by experienced professionals in the medical device and cryotherapy sectors, ensuring a strong foundation for its innovations.
Saturas is a precision agriculture company that develops and manufactures stem water potential SWP sensor systems for irrigation management. Its miniature sensors are embedded in the trunks of trees, vines, and other crops, providing direct contact with water tissues to deliver accurate, real-time measurements of plant water status. The system comprises implanted sensors, in-orchard wireless transponders, and a control unit that transmits data to a central system connected to irrigation controllers. This enables automated, real-time irrigation tailoring to crop needs, reducing water usage while aiming to increase fruit production, size, and sugar content. Saturas' technology supports vineyards and other crops by delivering easy-to-read reports to farmers and enabling precise irrigation decisions. The company was founded in 2013 and is based in Misgav, Israel.
AgroScout
Seed Round in 2020
AgroScout Ltd. is an Israeli company established in 2017 that specializes in developing an artificial intelligence-based platform aimed at enhancing sustainable farming practices. The company's technology provides precision agriculture solutions by utilizing advanced analytics and high-resolution aerial imagery to assess crop health and monitor for pests and diseases. AgroScout's platform supports farmers by offering insights on crop emergence, stand counts, canopy coverage, and biomass throughout the growing season. This continuous monitoring allows for early detection of infestations, enabling more effective curative treatments and reducing pesticide use. By delivering actionable insights into crop management and regional outbreak predictions, AgroScout aims to improve crop yields and profitability while fostering a more sustainable food production supply chain.
BioFishency
Venture Round in 2019
BioFishency develops integrated water treatment solutions for land‑based aquaculture. Its plug‑and‑play system operates across extensive ponds, constructed ponds, and recirculating systems, allowing farms to double or triple production while retaining existing infrastructure. The technology addresses limited water availability and toxic ammonia buildup, improving water quality to enhance fish survival, growth, and reproduction. A cloud‑controlled, temperature‑agnostic platform delivers immediate operation, reduces water and energy use, eliminates off‑flavors, and lowers the carbon footprint, thereby boosting yields and operational efficiency.
Saturas is a precision agriculture company that develops and manufactures stem water potential SWP sensor systems for irrigation management. Its miniature sensors are embedded in the trunks of trees, vines, and other crops, providing direct contact with water tissues to deliver accurate, real-time measurements of plant water status. The system comprises implanted sensors, in-orchard wireless transponders, and a control unit that transmits data to a central system connected to irrigation controllers. This enables automated, real-time irrigation tailoring to crop needs, reducing water usage while aiming to increase fruit production, size, and sugar content. Saturas' technology supports vineyards and other crops by delivering easy-to-read reports to farmers and enabling precise irrigation decisions. The company was founded in 2013 and is based in Misgav, Israel.
ElastiMed
Venture Round in 2017
ElastiMed develops innovative medical devices, initially focusing on smart compression therapy. Its flagship product is a wearable device using proprietary smart materials to improve leg circulation, treating Chronic Venous Insufficiency and preventing Deep Venous Thrombosis.
FruitSpec
Seed Round in 2017
FruitSpec develops hyperspectral imaging and deep learning based technology to estimate fruit yields and manage the fruit value chain. The company designs sensor pods that scan orchards and pairs them with a software platform to count fruits, determine size distribution, and estimate total yield. It offers yield estimation as a service, delivering reports that show the number of fruits and size distribution for a given orchard, with an additional heat-map visualization of fruit quantities. The solutions enable agribusinesses, including farmers, distributors, and insurers, to capture farm data and make planning decisions. Founded in 2016 and based in Tel Aviv, Israel, FruitSpec targets early-season insights to support demand-to-supply management across the fruit industry.
Gordian Surgical
Series A in 2016
Founded in 2012, Gordian Surgical develops innovative laparoscopy equipment. Its flagship product, TroClose 1200, is an integrated port closure solution used to open and suture close the abdominal wall during laparoscopic procedures.
Eden Shield
Convertible Note in 2016
EdenShield Ltd. is an Israel-based AgTech company founded in 2012, specializing in the development of nontoxic insect control products for greenhouse crops. The company offers a range of organic and chemical-free solutions, including EdenNet, EdenDirect, and EdenForte, which are formulated from botanical extracts and nutrients derived from native Israeli semi-desert plants. These products utilize proprietary aromatic ingredients that mask plant odors and reduce insect attraction, effectively preventing pest-related damage and the spread of viruses. EdenShield's innovative approach helps growers enhance the yield and health of crops, including cannabis, vegetables, and flowers, while promoting environmentally friendly agricultural practices.
Saturas
Seed Round in 2016
Saturas is a precision agriculture company that develops and manufactures stem water potential SWP sensor systems for irrigation management. Its miniature sensors are embedded in the trunks of trees, vines, and other crops, providing direct contact with water tissues to deliver accurate, real-time measurements of plant water status. The system comprises implanted sensors, in-orchard wireless transponders, and a control unit that transmits data to a central system connected to irrigation controllers. This enables automated, real-time irrigation tailoring to crop needs, reducing water usage while aiming to increase fruit production, size, and sugar content. Saturas' technology supports vineyards and other crops by delivering easy-to-read reports to farmers and enabling precise irrigation decisions. The company was founded in 2013 and is based in Misgav, Israel.
Eden Shield
Seed Round in 2016
EdenShield Ltd. is an Israel-based AgTech company founded in 2012, specializing in the development of nontoxic insect control products for greenhouse crops. The company offers a range of organic and chemical-free solutions, including EdenNet, EdenDirect, and EdenForte, which are formulated from botanical extracts and nutrients derived from native Israeli semi-desert plants. These products utilize proprietary aromatic ingredients that mask plant odors and reduce insect attraction, effectively preventing pest-related damage and the spread of viruses. EdenShield's innovative approach helps growers enhance the yield and health of crops, including cannabis, vegetables, and flowers, while promoting environmentally friendly agricultural practices.
Catalyst AgTech
Seed Round in 2014
Catalyst AgTech Ltd. is an Israeli company focused on developing innovative technology for the agriculture sector, specifically aimed at minimizing the environmental impact of agrochemical products. The company has created a customizable technology with a self-destruction mechanism designed for use in persistent pesticides, herbicides, and fungicides. This patented catalyst technology effectively breaks down specific chemicals in fertilizers, significantly reducing their harmful effects after application and preventing groundwater contamination. By addressing the growing demand for essential pesticides while mitigating adverse environmental consequences, Catalyst AgTech offers a solution that promotes sustainable agricultural practices. The company is supported by an experienced management team and benefits from scientific collaboration with the Weizmann Institute of Science.
Valentis Nanotech
Seed Round in 2014
Valentis Nanotech, established in 2013, specializes in the production of innovative polymeric films, coatings, and compounds utilizing cellulose nanocrystals (CNC) combined with nanoparticles. The company's patented technology enables the creation of biodegradable and transparent materials derived from plant pulp waste, resulting in films that are thin, strong, and environmentally friendly. These films offer enhanced properties, such as improved strength, better spectral control, and effective barriers against UV rays, oxygen, and moisture. Valentis has engaged in collaborations with a prominent agricultural thermoplastics company in Israel since July 2014, focusing on new product development to meet specific industry needs.
LapSpace Medical
Seed Round in 2013
LapSpace Medical Ltd. is a company based in Misgav, Israel, that specializes in the development of innovative devices for laparoscopic surgery. Founded in 2011, the company focuses on creating an inflatable balloon retractor designed to enhance surgical procedures. This retractor effectively and gently retracts abdominal organs, such as the intestines, thereby minimizing complications and shortening operating times. Additionally, it reduces the need for extra assistance during surgery, ultimately leading to lower costs and facilitating quicker patient recovery with minimal incisions. The LapSpace team combines extensive business expertise with medical knowledge, positioning the company as a key player in advancing laparoscopic techniques.
ApiFix develops a minimally invasive scoliosis deformity correction system for treating Adolescent Idiopathic Scoliosis (AIS). Its unique ratchet mechanism enables incremental corrections over several months, reducing the need for aggressive surgery.
Immunovative Therapies
Venture Round in 2012
Immunovative Therapies Ltd. is a biopharmaceutical company based in Jerusalem, Israel, focused on developing innovative immunotherapy products to treat cancer and infectious diseases in adult patients. Established in 2004, the company specializes in using living immune cells as active ingredients in its therapies. Key products include AlloStim, which utilizes activated T-Stim cells for infusion; CryoVax, an in-situ therapeutic cancer vaccine targeting disseminated metastatic tumors; CRCL, a source of patient-specific tumor antigens; and AlloVax, an individualized anti-cancer vaccine designed to educate the immune system during cancer remission to prevent recurrence. Immunovative Therapies develops treatment protocols for various conditions, including hematological malignancies, prostate cancer, breast cancer, glioblastoma multiforme, colorectal cancer with liver metastases, kidney cancer, and non-small cell lung cancer. The company's mission is to enhance patient quality of life and provide effective treatment options through its novel immunotherapeutic approaches.
InnoLap Surgical
Venture Round in 2012
InnoLap Surgical develops a device for scarless laparoscopic procedures. The device comprises a handle, thin 3 mm needle, and 5-10 mm detachable and replaceable operating heads. The company was founded in 2012 and is based in Misgav, Israel. As of September 30, 2013, InnoLap Surgical Ltd. operates as a subsidiary of Teleflex Incorporated.
Nephera Ltd., established in 2008 and headquartered in Misgav, Israel, specializes in developing medical devices for treating kidney dysfunction associated with chronic health conditions. The company's flagship product is an implantable pulse generator designed to enhance and maintain kidney functionality in patients suffering from congestive heart failure (CHF). This device operates by modulating sympathetic nerve activity through electrical stimulation of the urinary tract, thereby preserving renal function and improving diuretic therapy outcomes during frequent hospitalizations.
LifeBond
Seed Round in 2007
LifeBond Ltd. is a developer and manufacturer of absorbable bio-surgical medical devices focused on tissue repair, aiming to enhance patient recovery and support the body's natural healing process. Founded in 2006 and based in Caesarea, Israel, the company offers a range of products, including the LifeSeal Surgical Sealant, which provides reinforcement to minimize post-operative complications such as staple-line leakage in various surgical procedures. Another key product, LifeMesh Self-Fixating Mesh, is designed for secure fixation during hernia repair, addressing post-surgical complications effectively. In addition to these products, LifeBond is engaged in the development of tissue adhesives and absorbable hemostats. Their innovative devices are designed to meet a variety of surgical needs and are available in markets including China, the United States, and Europe, although many products remain investigational and have not yet received market approval.
BioSight
Venture Round in 2007
BioSight Ltd., established in 1999 and headquartered in Lod, Israel, is a biopharmaceutical company specializing in the development of innovative cancer-targeted pro-drugs. It focuses on creating non-toxic conjugates like its cytarabine-asparagine conjugate for treating acute myeloid leukemia patients worldwide. BioSight's proprietary technology, S2DOT™, enables targeted drug release inside cancer cells, minimizing systemic toxicity compared to conventional chemotherapy treatments.
Immunovative Therapies
Seed Round in 2004
Immunovative Therapies Ltd. is a biopharmaceutical company based in Jerusalem, Israel, focused on developing innovative immunotherapy products to treat cancer and infectious diseases in adult patients. Established in 2004, the company specializes in using living immune cells as active ingredients in its therapies. Key products include AlloStim, which utilizes activated T-Stim cells for infusion; CryoVax, an in-situ therapeutic cancer vaccine targeting disseminated metastatic tumors; CRCL, a source of patient-specific tumor antigens; and AlloVax, an individualized anti-cancer vaccine designed to educate the immune system during cancer remission to prevent recurrence. Immunovative Therapies develops treatment protocols for various conditions, including hematological malignancies, prostate cancer, breast cancer, glioblastoma multiforme, colorectal cancer with liver metastases, kidney cancer, and non-small cell lung cancer. The company's mission is to enhance patient quality of life and provide effective treatment options through its novel immunotherapeutic approaches.